KSS
42
4
AA
47
4
HUM
39
9
ALLE
44
5
EMC
71
9
NSC
53
6
NUE
51
3
NRG
67
8
CHRW
53
3
RF
54
3
BWA
44
3
BLK
69
3
MDLZ
38
2
GME
57
2
WBA
53
5
MCD
54
4
VLO
33
3
MU
39
5
BK
69
4
DOV
61
4
KSS
42
4
AA
47
4
HUM
39
9
ALLE
44
5
EMC
71
9
NSC
53
6
NUE
51
3
NRG
67
8
CHRW
53
3
RF
54
3
BWA
44
3
BLK
69
3
MDLZ
38
2
GME
57
2
WBA
53
5
MCD
54
4
VLO
33
3
MU
39
5
BK
69
4
DOV
61
4
Financhill
Back

Novo Nordisk AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
27

NONOF
Novo Nordisk AS

Last Price:
106.21
Seasonality Move:
9.66%
Sell
27

ASND
Ascendis Pharma AS

Last Price:
127.98
Seasonality Move:
11.25%
Sell
27
Novo Nordisk AS (NONOF) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NONOF] share price is $106.21. The Score for NONOF is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NONOF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $128.13. The Score for ASND is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NONOF Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $106.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing selling pressure, which indicates risk of future bearish movement.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $128.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

NONOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 33.44 Sell
Chaikin Money Flow: -23361 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.38 - 119.06) Sell
Bollinger Bands (100): (119.42 - 140.4) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.75 Sell
Relative Strength Index (14 RSI): 46.53 Sell
Chaikin Money Flow: 189333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.62 - 137.64) Sell
Bollinger Bands (100): (125.03 - 141.83) Sell

NONOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 110.81 Sell
20-day SMA: 114.93 Sell
50-day SMA: 123.26 Sell
200-day SMA: 128.08 Sell
8-day EMA: 110.63 Sell
20-day EMA: 114.37 Sell
50-day EMA: 120.7 Sell
200-day EMA: 122.52 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 126.38 Buy
20-day SMA: 128.13 Sell
50-day SMA: 133.2 Sell
200-day SMA: 137.43 Sell
8-day EMA: 126.59 Buy
20-day EMA: 129.14 Sell
50-day EMA: 132.14 Sell
200-day EMA: 130.84 Sell

Novo Nordisk AS Earnings Growth & NONOF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $0.55 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.70 per share, and an increase next year of $4.28 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):